Zika virus infectious cell culture system and the in vitro prophylactic effect of interferons

Journal of Visualized Experiments

Volumn 2016, Issue 114, 2016, Pages

  Contreras, Deisy ^a   Arumugaswami, Vaithilingaraja ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytokines; Emerging disease; Flaviviridae; IFN ; IFN ; Infection; Interferon; Issue 114; Microcephaly; Mosquito borne illness; Zika Virus; Zika virus prophylaxis; ZIKV; ZIKV inhibitors

Indexed keywords

DOUBLE STRANDED RNA; INTERFERON; VIRUS RNA;

ANIMAL; CELL LINE; FEMALE; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION; VIRAL PLAQUE ASSAY; VIROLOGY; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

ANIMALS; CELL LINE; FEMALE; GENOME, VIRAL; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; INTERFERONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RNA, DOUBLE-STRANDED; RNA, VIRAL; VIRAL LOAD; VIRAL PLAQUE ASSAY; VIRUS REPLICATION; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84983732287     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/54767     Document Type: Article

References (19)

1. Brasil, P., et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro - Preliminary Report. N Engl J Med. 1-11 (2016).
2. Lucey, D.R. and L.O. Gostin. The Emerging Zika Pandemic: Enhancing Preparedness. JAMA. 315(9), 865-866 (2016).
3. Mlakar, J., et al. Zika Virus Associated with Microcephaly. N Engl J Med. 374 (10), 951-958 (2016).
4. Schuler-Faccini, L., et al. Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. MMWR Morb Mortal Wkly Rep. 65 (3), 59-62 (2016).
5. Foy, B.D., et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 17 (5), 880-2 (2011).
6. Kuno, G. and G.J. Chang. Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses. Arch Virol. 152 (4), 687-96 (2007).
7. Dick, G.W. Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg. 46 (5), 521-34 (1952).
8. Dick, G.W., Kitchen, S.F., and Haddow, A.J. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 46 (5), 509-20 (1952).
9. Oehler, E., et al. Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013. Euro Surveill. 19 (9), 1-3 (2014).
10. Baronti, C., et al. Complete coding sequence of zika virus from a French polynesia outbreak in 2013. Genome Announc. 2 (3), e00500-14 (2014).
11. Lanciotti, R.S., et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 14 (8), 1232-1239 (2008).
12. Lanciotti, R.S., et al. Phylogeny of Zika virus in Western Hemisphere, 2015 [Letter]. Emerg Infect Dis. 22 (5) (2016).
13. Musso, D., Nilles, E.J., and Cao-Lormeau, V.M. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect. 20 (10), O595-596 (2014).
14. Tang, H., et al. Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth. Cell Stem Cell. 1-5 (2016).
15. Hamel, R., et al. Biology of Zika Virus Infection in Human Skin Cells. J Virol. 89 (17), 8880-8896 (2015).
16. Faye, O., et al. Quantitative real-time PCR detection of Zika virus and evaluation with field-caught mosquitoes. Virol J. 10, 311 (2013).
17. Chu, D., et al. Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome. J Virol. 87 (10), 5678-5696 (2013).
18. Hiratsuka, M., et al. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med. 28 (5),372-376 (2000).
19. Ozaslan, E., et al. Interferon therapy for acute hepatitis C during pregnancy. Ann Pharmacother. 36 (11), 1715-8 (2002).